Alex Fudukidis | Director of Investor Relations |
Adi Hoess | Chief Executive Officer |
Andreas Harstrick | Chief Medical Officer |
Angus Smith | Chief Financial Officer |
Wolfgang Fischer | Chief Operating Officer |
Arndt Schottelius | Chief Scientific Officer |
Maurice Raycroft | Jefferies |
Li Watsek | Cantor Fitzgerald |
Srikripa Devarakonda | Truist Securities |
Bradley Canino | Stifel |
Yale Jen | Laidlaw |
Yanan Zhu | Wells Fargo Securities |
Good day, everyone and welcome to Affimed's First Quarter 2023 Earnings and Corporate Update Call. At this time, all participants are in a listen-only mode. After the presentation there will be a question-and-answer session. [Operator Instructions] As a reminder, today's conference is being recorded.
I would now like to introduce your host for today's call, Alex Fudukidis, Head of Investor Relations at Affimed.